BASF completes $10bn chemical complex deal in China

By Sean Galea-Pace
Share
The Germany-based company BASF has completed a preliminary deal to create the first wholly foreign-owned chemicals complex in China, sources close to th...

The Germany-based company BASF has completed a preliminary deal to create the first wholly foreign-owned chemicals complex in China, sources close to the deal revealed as reported by Reuters.

Despite the current trade tensions between Beijing and Washington, the deal has been considered to have reached completion in a relatively short time frame.

The new facility is set to be located in China’s in a largely densely populated province in Guangdong and is estimated to cost $10bn in investment.

There were concerns that a US and China trade war could hurt potential investments in the area, however, local government officials have been open to the advances of BASF.

See more:

Chinese Premier, Li Keqiang, met German Chancellor, Angela Merkel, in Berlin earlier this week as part of the unveiling of $23bn worth of bilateral deals between the two countries.

“Now that we have this trade war that was kicked off last week, Beijing is telling Washington that it is still doing business and that there are capable companies around the world to do business with,” said John Driscoll, JTD Energy’s Director of Consultancy.

The trade dispute has intensified after it was revealed on 10 July that the Trump administration has threatened to implement 10% tariffs on a range of Chinese imported products worth $200 billion.

It is anticipated that this could lead to a retaliation from Beijing in which it could escalate the trade war.

Share

Featured Articles

Axiado & Pegatron Partner to Boost Server Security

Axiado and Pegatron's collaboration enhances server security for manufacturing, delivering robust AI-driven protection for modern industrial data centres

Genus Power Showcases Smart Metering Innovation & Diversity

Genus Power impresses US delegation with cutting-edge smart metering technology and a diverse workforce, advancing global clean energy solutions

Telix's bid to Expand Access to Cancer Radiopharmaceuticals

Rhine Pharma, spun off by Telix, aims to open production to improve worldwide access to radiopharmaceuticals for cancer imaging & treatment

UK Automotive Manufacturers Face Net Zero Challenge

Sustainability & ESG

Samsung Biologics Secures US$1.24Bn Manufacturing Deal

Production & Operations

How is ABB Revolutionising Automotive Sustainability?

Sustainability & ESG